Although first results from COVID-19 patients treated with these repurposed drugs have been conflicting (31–33), the role of Pyrin (the inflammasome sensor protein that is encoded by MEFV) in modulating severity and outcome of COVID-19 is still unknown. This evidence concerns the gene MEFV and COVID-19.